Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

FutureChem Co., Ltd. engages in the manufacture of medical products. Its products include radiopharmaceutical, automation module, chemicals, linkers (bioconjugation), ionic liquids and custom synthesis. In addition, it also engages in the research and development of radioisotope labeling. The company was founded on August 13, 2001 and is headquartered in Seoul, South Korea.

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.

Rad Source Technologies, Inc. develops and sells x-ray technology product for medical and scientific. It provides providing renewable, non-isotope, ionizing radiation replacements for self-shielded gamma irradiators, hospital, university, and pharmaceutical research institutions using Rad Source X-ray technology. The company was founded by Randol Kirk in 1997 and is headquartered in Suwanee. GA.

Meso Scale Technologies LLC is a biotechnology company. It provides chemiluminescence based detection technologies and products. The company was founded by Jacob N. Wohlstadter in1995 and is headquartered in Wilmington, DE.

Technology & Innovation Corp. AD engages in the management of financial securities. It is an investment holding company which acquires and evaluates shares, bonds and patents of companies. The company was founded in 1992 and is headquartered in Plovdiv, Bulgaria.

BCN Biosciences is developing novel drugs in oncology as well as for the protection of normal tissues from radiation damage. They are committed to improving cancer treatment and diagnosis. The company manufactures innovative and effective medicines to treat cancer, one of the most serious diseases, with a team of experts in both drug discovery and oncology.

Egg Medical is a medical device company that offers EGGNEST, a passive protection designed to drastically reduce scatter radiation exposure for the entire cath lab team without disruption to workflow. It is an in integrated work platform built on a carbon fiber sled base designed to drastically reduce scatter radiation exposure without disrupting workflow.

TdeltaS Ltd. is a British company located in Oxfordshire that provides commercial, physical and biological research and development services. The firm was founded in 2005.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Menta SRL is a private company headquartered in Italy that engages in carpentry in iron, stainless steel and aluminum.

Korea Hydro & Nuclear Power Co. Ltd. produces and supplies electric power. It operates nuclear plants in Busan, Ulsan, North-Gyeongsang, and North-Jeonla and renewable energy generation facilities. The company was founded on April 2, 2001 and is headquartered in Seoul, South Korea.

Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification and targeting of disease at the molecular level to improve patient healthcare by addressing significant unmet medical needs. They are focused on discovering, developing and commercializing innovative and targeted radiotherapeutics and molecular imaging pharmaceuticals with initial applications in the areas of oncology and cardiology.

Bioincept LLC provides pre-implantation factor technologies as they relate to animal and human diagnostic and therapeutic health products. The company was founded by Dr. Jacqueline H. Barnea and Dr. Eytan R. Barnea in 2001 and is headquartered in Cherry Hill, NJ.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.